Skip to main content

National Institutes of Health Patient-Reported Outcomes Measurement Information System (NIH PROMIS, 2013).

National Institutes of Health Patient-Reported Outcomes Measurement Information System (NIH PROMIS, 2013)

The NIH PROMIS is a database of self-report measures for monitoring patient symptoms in four domains (i.e., global, physical, mental, and social health) in adults. The Mental Health profile item banks (i.e., depression and anxiety) are the most directly related to community mental health. Both item banks are available in short forms (ranging from 4- to 8-items) and long forms (approximately 30 items).  These tools can be used as screening instruments (Broderick, DeWitt, Rothrock, Crane, & Forrest, 2013). No information on use with adolescents was available. All items are available in Spanish, with translations and validations pending in Dutch, Portuguese, Hindi, and Mandarin. Below, we have described the Depression and Anxiety banks. Additional mental health item banks include Anger; Applied Cognition; Alcohol Use, Consequences and Expectancies; and Psychosocial Illness Impact. The psychometric analysis is still pending for these item banks.

The PROMIS Depression item bank assesses depressive effects such as negative mood (e.g., sadness, guilt) and negative social cognition (e.g., loneliness, interpersonal alienation). Sample items include “I felt worthless” and “I felt helpless.” Each item is rated on a scale from one (“never”) to five (“always”). The full depression bank (28 items) demonstrates excellent alternate-form reliability (r = .96) and concurrent validity with the 8-item short form. In addition, the depression item bank demonstrates acceptable to good concurrent validity with the Center for Epidemiological Studies-Depression Scale (CES-DS; Radloff, 1977) and the Mood and Anxiety Symptom Questionnaire (MASQ; Watson & Clark, 1991).   

The PROMIS Anxiety item bank assesses aspects of anxiety symptomatology such as fear (e.g., feelings of panic) and anxious misery (e.g., worry, dread). Sample items include “I felt like something awful might happen” and “I worried about what could happen to me.” Each item is rated from one (“never”) to five (“always”). The full anxiety bank (29 items) demonstrates excellent alternate-form reliability (r = .96) and concurrent validity with the 7-item short form. The Anxiety item bank demonstrates concurrent validity with the Center for Epidemiological Studies-Depression Scale (CES-DS; Radloff, 1977) and the Mood and Anxiety Symptom Questionnaire (MASQ; Watson & Clark, 1991).

Brief forms are available at:

(https://www.assessmentcenter.net/PromisForms.aspx).

Full forms are available by creating an account through the PROMIS Assessment Center.

(www.assessmentcenter.net).

Comments

Popular posts from this blog

ADVOKATE: A Tool for Assessment of Eyewitness Evidence

ADVOCATE: A Tool for Assessment of Eyewitness Evidence It is a tool designed to assess the eyewitness evidence that how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologist, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)

Diagnostic test for catatonia, the lorazepam challenge test

Benzodiazepines are the mainstay of the treatment of catatonia and are also helpful as a diagnostic probe. A positive Lorazepam Challenge Test validates the diagnosis of catatonia. After we examine the patient for signs of catatonia, 1 or 2 mg of lorazepam is administered intravenously. After 5 minutes, the patient is re-examined. If there has been no change, a second dose is given, and the patient is again reassessed (46, 78). A positive response is a marked reduction (e.g., at least 50%) of catatonic signs and symptoms, as measured with a standardized rating scale. Favorable responses usually occur within 10 min (46). If lorazepam is given intramuscularly or per os, the interval for the second dose should be longer: 15′ and 30′, respectively. Many clinicians will share the experience that a “lorazepam test” not only confirms the diagnosis of catatonia but that it also makes the underlying psychopathology apparent “by permitting mute patients to speak” (79). Analogous to the lorazepa

Classification of Depression According to the ICD-10

A first depressive episode, duration at least15 days →depressive episode (F32)  A first depressive episode, severe and rapid onset, duration less than 15 days →still depressive episode (F32) A depressive episode can be mild (2 core symptoms, 2 other symptoms from the list) (32.0) moderate (2 core symptoms, 3 or preferably 4 other symptoms) (32.1) Severe (3 core symptoms, 4 other symptoms) without psychotic symptoms (32.2) (no delusion, hallucination or stupor) Severe with psychotic symptoms (above plus either delusions, hallucinations or stupor) (F32.3) Delusions can be mood-congruent or incongruent (neutral delusions e.g. delusions of reference are considered mood incongruent. None of them count towards schizoaffective disorder unless one of the first-rank)  A mild and moderate depressive episode can be  with somatic syndrome (four or more somatic symptoms, or three very severe somatic symptoms) without somatic syndrome (three or less somatic symptoms, not severe)  A severe depressi